Related Experiment Videos
Pharmacokinetics of high-dose methylprednisolone in children
S Ito1, Y Kusunoki, T Oka
1Department of Pediatrics, Asahikawa Medical College, Japan.
Insights
High-dose methylprednisolone in children shows rapid conversion and a mean half-life of 2.5 hours. However, clearance varies fivefold, indicating significant differences in drug exposure among pediatric patients.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Metabolism
Background:
- Methylprednisolone is a widely used corticosteroid in pediatric treatment.
- Understanding its pharmacokinetic profile is crucial for optimizing therapeutic outcomes and minimizing adverse effects in children.
Purpose of the Study:
- To characterize the disposition and pharmacokinetics of high-dose methylprednisolone in pediatric patients.
- To assess interindividual variability in methylprednisolone clearance and exposure during high-dose pulse therapy.
Main Methods:
- Pharmacokinetic analysis of methylprednisolone serum concentrations in 11 children receiving high-dose intravenous therapy.
- Calculation of key pharmacokinetic parameters including half-life, mean residence time, volume of distribution, and clearance.
Main Results:
- Methylprednisolone hemisuccinate rapidly converted to methylprednisolone (half-life ~20 min).
- Mean serum methylprednisolone terminal half-life was 2.5 hours, with a volume of distribution of 1.3 L/kg and clearance of 0.5 L/kg/h.
- Significant fivefold interindividual variability in clearance was observed, suggesting large differences in drug exposure.
Conclusions:
- High-dose methylprednisolone exhibits predictable initial disposition in children.
- Substantial interindividual variability in clearance highlights the need for personalized dosing or therapeutic drug monitoring in pediatric high-dose pulse therapy.
Abstract:
Disposition of methylprednisolone was characterized in 11 children receiving the high-dose therapy (26.0 mg/kg on average). After intravenous infusion, methylprednisolone hemisuccinate was rapidly converted to methylprednisolone with a half-life of about 20 min. Methylprednisolone in serum, eliminated monoexponentially in 8 patients and biexponentially in the remaining three, had the mean residence time of about 3 h, and a terminal half-life of 2.5 h. The volume of distribution at steady state, and the clearance were 1.3 liters/kg and 0.5 liters/kg/h, respectively. Although these average pharmacokinetic parameters were comparable to those determined in other studies with conventional low doses, the clearance values in our data were characterized by 5-fold interindividual difference, suggesting large variations in exposures to methylprednisolone among children on the high-dose pulse therapy.